Eliglustat Tartrate Patent Expiration

Eliglustat Tartrate is used for long-term treatment of Gaucher disease type 1. It was first introduced by Genzyme Corp in its drug Cerdelga on Aug 19, 2014. 6 different companies have introduced drugs containing Eliglustat Tartrate.


Eliglustat Tartrate Patents

Given below is the list of patents protecting Eliglustat Tartrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cerdelga US10888544 Methods for treating Gaucher disease Dec 13, 2038 Genzyme Corp
Cerdelga US10888547 Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase Jan 31, 2031 Genzyme Corp
Cerdelga US11458119 Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase Nov 24, 2030 Genzyme Corp
Cerdelga US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Jun 26, 2026 Genzyme Corp
Cerdelga US6916802 Amino ceramide-like compounds and therapeutic methods of use Apr 29, 2022

(Expired)

Genzyme Corp
Cerdelga US7253185 Amino ceramide-like compounds and therapeutic methods of use Apr 29, 2022

(Expired)

Genzyme Corp
Cerdelga US7615573 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Apr 29, 2022

(Expired)

Genzyme Corp



Eliglustat Tartrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Eliglustat Tartrate Generics

Several generic applications have been filed for Eliglustat Tartrate. The first generic version for Eliglustat Tartrate was by Aizant Drug Research Solutions Pvt Ltd and was approved on Sep 8, 2021. And the latest generic version is by Apotex Inc and was approved on Jul 10, 2024.

Given below is the list of companies who have filed for Eliglustat Tartrate generic.


1. AIZANT

Aizant Drug Research Solutions Pvt Ltd has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Aizant.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 84MG BASE capsule Prescription ORAL AB Sep 8, 2021


2. APOTEX

Apotex Inc has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 84MG BASE capsule Prescription ORAL AB Jul 10, 2024


3. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 84MG BASE capsule Discontinued ORAL N/A Aug 17, 2022


4. TEVA PHARMS USA INC

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 84MG BASE capsule Discontinued ORAL N/A Dec 27, 2021


5. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 1 generic for Eliglustat Tartrate. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 84MG BASE capsule Prescription ORAL AB May 2, 2023